Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Ciprofloxacin and cefotaxime help resistant bacteria thrive in hospital sewage (opens in a new tab)

medicalxpress.com · 2026-10-29

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. One other point was not covered by the paper.

  • 2 supported
  • 1 overstated
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Two of four check out. One claim the study doesn't address.

  • 2 supported
  • 1 overstated
  • 1 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

  • The study this story reportsmentioned without context

    Widespread selection of antibiotic resistance within hospital sewers

    Nature Communications · 2026

    Publisher (opens in a new tab)
  • The study this story reportspresented as the new finding

    Widespread selection of antibiotic resistance within hospital sewers

    Nature Communications · 2026

    Publisher (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4OverstatedThe researchers say the findings suggest similar resistance selection occurs in the sewers of most hospitals worldwide, and that hospital sewage systems are a critical site for targeted interventions.View evidenceHide evidence

As statedmost hospitals worldwide

Why this verdict

The paper profile supports extrapolating selection risk beyond Sweden using antibiotic concentration and use data, and it supports prioritizing mitigation in hospital sewers. But the story’s 'most hospitals worldwide' framing is broader than the abstract-level evidence: the primary empirical data are Swedish, and the beyond-Sweden component is an extrapolative/modeling inference rather than direct worldwide field evidence. The intervention point is supported, but the global prevalence wording is overstated.

1

Study evidence

Measured antibiotic concentrations combined with antibiotic use data were used to extrapolate the risk of selection for antibiotic resistance beyond Sweden.

“Antibiotic concentrations and use data allow extrapolation of risks beyond Sweden.”
2

Study evidence

Filtered wastewater from ten hospitals consistently selected for multiple antibiotic resistances in Escherichia coli, whereas paired municipal wastewaters did not.

“consistent selection of multiple resistances in Escherichia coli exposed to filtered wastewater from ten hospitals, but not to corresponding municipal wastewaters”
Claim 2 of 4Not coveredThe study examined sewer systems and wastewater from hospitals and municipal treatment plants in eight Swedish cities; sewage from all 10 hospitals promoted antibiotic-resistant bacteria, while no such effects were found after exposure to sewage from the corresponding municipal treatment plants.View evidenceHide evidence

As statedall 10 hospitals; eight Swedish cities

Why this verdict

The abstract profile supports consistent selection for multiple resistances in E. coli exposed to filtered wastewater from ten hospitals, and no comparable selection in corresponding municipal wastewaters. However, the exact sampling frame as stated by the story—'eight Swedish cities' and 'municipal treatment plants'—is not available in the abstract-level profile, which refers more generally to Swedish hospital versus municipal wastewater/sewer sites. The core hospital-versus-municipal result is supported, but the full claim as framed is not fully verifiable at this depth.

1

Study evidence

Filtered wastewater from ten hospitals consistently selected for multiple antibiotic resistances in Escherichia coli, whereas paired municipal wastewaters did not.

“consistent selection of multiple resistances in Escherichia coli exposed to filtered wastewater from ten hospitals, but not to corresponding municipal wastewaters”
Claim 3 of 4SupportedAntibiotics excreted by patients promote antibiotic-resistant bacteria in hospital sewers, according to a new study by researchers at the University of Gothenburg, Sweden.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the headline-level causal framing that hospital sewer/wastewater environments select for antibiotic-resistant bacteria, with ex vivo exposure assays, in-situ sewer biofilm enrichment, and mechanistic/chemical evidence implicating antibiotics. The specific wording that antibiotics are 'excreted by patients' is contextual rather than separately detailed in the abstract profile, but the central causal claim about antibiotic-driven selection in hospital sewers is supported.

1

Study evidence

Filtered wastewater from ten hospitals consistently selected for multiple antibiotic resistances in Escherichia coli, whereas paired municipal wastewaters did not.

“consistent selection of multiple resistances in Escherichia coli exposed to filtered wastewater from ten hospitals, but not to corresponding municipal wastewaters”
2

Study evidence

In-situ enrichment of antibiotic-resistant over antibiotic-sensitive Escherichia coli from wastewater into sewer biofilms was observed at hospital sites but not at municipal sites, as measured by culture-based quantification in a comparative field assay.

“in-situ enrichment of resistant over sensitive E. coli from wastewater to sewer biofilms at hospitals, but not at municipal sites”
Claim 4 of 4SupportedCiprofloxacin was identified as a key driver, and cefotaxime also contributed to the resistance-selection effect in hospital sewage.View evidenceHide evidence

Why this verdict

The profile supports ciprofloxacin and cefotaxime as principal selective agents: LC-MS/MS measurements compared with selective thresholds identified them, and genetic rescue/phenotype evidence supports fluoroquinolone and β-lactam involvement. The causal framing is consistent with the mechanistic evidence summarized at abstract level.

1

Study evidence

Introducing resistance genes for fluoroquinolones and β-lactams into a sensitive E. coli background produced a complete rescue of the sensitive strain under hospital-wastewater exposure.

“complete rescue of sensitive E. coli by addition of resistance genes to fluoroquinolones and β-lactams”
2

Study evidence

The abstract reports 'cellular effects typical for β-lactams' in bacteria exposed in the hospital sewer/wastewater context, presented as mechanistic phenotype corroboration that β-lactams contributed to selection.

“cellular effects typical for β-lactams”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Culture-based and metagenomic field comparisons found higher resistance in bacteria from hospital sewers than from municipal sites.

    The story conveys the overall selection conclusion but does not specifically mention the culture-based and metagenomic evidence comparing bacteria collected from hospital versus municipal sewers.

    From Observational field sampling with culture and metagenomic assays

  • The extrapolation beyond Sweden is based on antibiotic concentration and use data rather than direct empirical measurement in non-Swedish hospital sewers.

    The story presents a broad worldwide implication but does not clearly state that the non-Swedish component is extrapolative and assumption-dependent, not direct global field measurement.

    From secondary_data

  • A major selection assay used filtered, cell-free wastewater and E. coli as a standardized test organism, which is not identical to whole-wastewater community dynamics in intact sewer ecosystems.

    The story describes sewage promoting resistant bacteria and emphasizes real sewer pipes, but it does not mention that one central experimental line was an ex vivo filtered-wastewater E. coli assay. The profile also contains in-situ evidence, so this omission does not negate the main finding, but it is a relevant methodological caveat.

    From ex_vivo_filtered_wastewater_exposure_and_comparative_field_assays

3 things the story did carry across
  • Hospital wastewater from ten hospitals selected for multiple antibiotic resistances in E. coli, while corresponding municipal wastewater did not show this effect in the reported assays.
  • In-situ sewer biofilm experiments showed enrichment of resistant over sensitive E. coli at hospital sites but not municipal sites, providing direct field evidence within sewer infrastructure.
  • Ciprofloxacin and cefotaxime/β-lactams were identified as principal selective agents using chemical measurements, threshold comparisons, and mechanistic assays.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

7

Evidence read

study summary

Lead result

ex vivo human

1Lead resultex vivo humanHospital sewer environments select for antibiotic-resistant bacteria (relative to municipal wastewater/sewers), demonstrated via exposure assays, in-situ biofilm enrichment, and field comparisons using culture and metagenomics.ex vivo filtered wastewater exposure and comparative field assaysExpand

In plain English

Ex vivo exposure assays using filtered wastewater from ten Swedish hospitals (compared with paired municipal wastewaters) produced consistent selection for multiple antibiotic resistances in Escherichia coli. Complementary in-situ assays showed enrichment of resistant over sensitive E. coli in hospital sewer biofilms but not at municipal sites, and culture-based and metagenomic surveys detected higher resistance in bacteria from hospital sewers. Genetic rescue experiments and cellular assays implicate fluoroquinolone and β-lactam selection, and LC-MS/MS measurements compared to selective thresholds identify ciprofloxacin and cefotaxime as principal selective agents. The authors use antibiotic concentration and use data to discuss extrapolation of risk beyond Sweden.

Key findings

  • Filtered wastewater from ten hospitals consistently selected for multiple antibiotic resistances in Escherichia coli, whereas paired municipal wastewaters did not.
  • In-situ assays showed enrichment of resistant over sensitive E. coli in sewer biofilms at hospital sites but not at municipal sites.
“consistent selection of multiple resistances in Escherichia coli exposed to filtered wastewater from ten hospitals, but not to corresponding municipal wastewaters”
What this piece can’t prove

2 further details could not be confirmed from the summary.

2otherHospital sewer environments select for antibiotic-resistant bacteria (relative to municipal wastewater/sewers), demonstrated via exposure assays, in-situ biofilm enrichment, and field comparisons using culture and metagenomics.Field in-situ biofilm colonization/enrichment assay (hospital vs municipal sewers)Expand

In plain English

Field in-situ biofilm colonization/enrichment experiments showed enrichment of antibiotic-resistant over sensitive Escherichia coli from wastewater into sewer biofilms at hospital sites but not at municipal sewer sites; enrichment was assessed using culture-based quantification in a comparative hospital-versus-municipal design.

Key findings

  • In-situ enrichment of antibiotic-resistant over antibiotic-sensitive Escherichia coli from wastewater into sewer biofilms was observed at hospital sites but not at municipal sites, as measured by culture-based quantification in a comparative field assay.
“in-situ enrichment of resistant over sensitive E. coli from wastewater to sewer biofilms at hospitals, but not at municipal sites”
What this piece can’t prove
  • The abstract does not specify which resistance determinants or E. coli strains were used/tracked in the in-situ biofilm assay.

1 further detail could not be confirmed from the summary.

3otherHospital sewer environments select for antibiotic-resistant bacteria (relative to municipal wastewater/sewers), demonstrated via exposure assays, in-situ biofilm enrichment, and field comparisons using culture and metagenomics.Observational field sampling with culture and metagenomic assaysExpand

In plain English

Observational field comparison of sewer microbiomes from hospital sewers versus municipal sites in Sweden, using culture-based phenotyping and metagenomic resistome profiling on directly collected samples; authors report higher levels of antibiotic resistance in bacteria from hospital sewers than from municipal sites by both measurement modalities, and in-situ enrichment of resistant versus sensitive Escherichia coli in hospital sewer biofilms but not at municipal sites.

Key findings

  • Bacteria cultured from hospital sewer samples exhibited higher antibiotic resistance than bacteria cultured from municipal sewer samples.
  • Metagenomic resistome profiles showed higher resistance-associated sequence abundance in hospital sewer samples compared to municipal sites.
“higher resistance in bacteria collected from hospital sewers than from municipal sites as assessed by culturing and metagenomics”
What this piece can’t prove
  • Observational field-comparative design reported in abstract limits causal inference about mechanisms driving higher resistance in hospital sewers.
  • Abstract does not provide site counts, sampling dates, sample sizes, or statistical details for the field comparisons.
  • Geographic scope appears to be Sweden; generalizability to other regions depends on local antibiotic use and sewer systems.

1 further detail could not be confirmed from the summary.

4in vitroSpecific antibiotics—especially ciprofloxacin and cefotaxime/β-lactams—are principal selective agents in hospital sewers, supported by genetic rescue/phenotype evidence and chemical measurements benchmarked against selection thresholds.in vitro genetic rescueExpand

In plain English

In vitro genetic-rescue experiments reported in the paper show that introducing resistance genes for fluoroquinolones and β-lactams into a sensitive Escherichia coli background produced a 'complete rescue' of the sensitive strain when exposed to hospital wastewater, providing mechanistic evidence that fluoroquinolones (e.g., ciprofloxacin) and β-lactams (e.g., cefotaxime) are principal selective agents in hospital sewers.

Key findings

  • Introducing resistance genes for fluoroquinolones and β-lactams into a sensitive E. coli background produced a complete rescue of the sensitive strain under hospital-wastewater exposure.
“complete rescue of sensitive E. coli by addition of resistance genes to fluoroquinolones and β-lactams”
What this piece can’t prove
  • Findings are based on in vitro genetic-rescue assays with E. coli; applicability to other taxa or to intact sewer biofilms/ecosystems is not directly demonstrated in this unit's description.

2 further details could not be confirmed from the summary.

5in vitroSpecific antibiotics—especially ciprofloxacin and cefotaxime/β-lactams—are principal selective agents in hospital sewers, supported by genetic rescue/phenotype evidence and chemical measurements benchmarked against selection thresholds.in vitro phenotype assaysExpand

In plain English

The paper reports observation of 'cellular effects typical for β-lactams' in bacteria exposed in the context of hospital sewers/wastewater. This phenotype-based observation is presented as a distinct mechanistic line of evidence supporting β-lactam (cefotaxime/β-lactam)–driven selection, complementary to genetic rescue experiments and chemical measurements described elsewhere in the study. The abstract does not provide experimental or quantitative detail for these cellular observations.

Key findings

  • The abstract reports 'cellular effects typical for β-lactams' in bacteria exposed in the hospital sewer/wastewater context, presented as mechanistic phenotype corroboration that β-lactams contributed to selection.
“cellular effects typical for β-lactams”
What this piece can’t prove
  • Unclear which bacterial taxa/strains were assessed for the cellular effects and whether findings were generalized across organisms.

3 further details could not be confirmed from the summary.

6ex vivo humanSpecific antibiotics—especially ciprofloxacin and cefotaxime/β-lactams—are principal selective agents in hospital sewers, supported by genetic rescue/phenotype evidence and chemical measurements benchmarked against selection thresholds.LC–MS/MS quantification of antibiotics with threshold benchmarkingExpand

In plain English

Antibiotic concentrations in hospital wastewater were measured by liquid chromatography–tandem mass spectrometry (LC–MS/MS) and compared to published/defined selective threshold concentrations; this analysis identified ciprofloxacin and cefotaxime (a β‑lactam) as principal selective agents in hospital sewers.

Key findings

  • LC–MS/MS–measured concentrations of antibiotics in hospital wastewater, when benchmarked against selective thresholds, indicate ciprofloxacin and cefotaxime as principal selective agents for resistance selection in hospital sewers.
“Measured concentrations by liquid-chromatography-tandem-mass-spectrometry compared to selective thresholds identify ciprofloxacin and cefotaxime as principal selective agents.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

7secondary dataAntibiotic concentration and use data can be used to extrapolate selection risk beyond Sweden and motivate prioritization of mitigation in hospital sewers.secondary dataExpand

In plain English

The authors combined measured antibiotic concentrations (LC‑MS/MS) with antibiotic use data and compared concentrations to selective thresholds to extrapolate the risk of selection for antibiotic resistance beyond Sweden; this analysis identified ciprofloxacin and cefotaxime as principal selective agents and motivated prioritizing mitigation in hospital sewers.

Key findings

  • Measured antibiotic concentrations combined with antibiotic use data were used to extrapolate the risk of selection for antibiotic resistance beyond Sweden.
  • Comparison of LC-MS/MS measured concentrations to selective thresholds identified ciprofloxacin and cefotaxime as principal selective agents in hospital sewers.
“Antibiotic concentrations and use data allow extrapolation of risks beyond Sweden.”
What this piece can’t prove
  • The analysis is an extrapolative/modeling exercise using concentration and use data rather than direct empirical measurement of selection risk in non-Swedish sewers.
  • Extrapolated risk estimates depend on the selective thresholds, antibiotic consumption data quality, and assumptions used to scale between settings.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Widespread selection of antibiotic resistance within hospital sewers

Nature Communications · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, Europe PMC, PubMed · 41 candidate papers

And 35 more candidates considered.